Two gastroenterologists spoke with Becker’s to discuss research challenges, advice for early-career physicians and more.
The physicians participated in a study published in The New England Journal of Medicine, showing the potential oral microbiome therapy SER-109 could have to fight recurrent C. diff.
Paul Feuerstadt, MD, is a practicing gastroenterologist at the PACT-Gastroenterology Center in Hamden, Conn. Louis Korman, MD, is co-director of Chevy Chase Clinical Research at Capital Digestive Care in Silver Spring, Md.